(4-Methyl-1H-indol-3-yl)methanol, 95.0%, 1g

2-(2-(2-(4-Nitrophenoxy)ethoxy)ethoxy)ethanol, 98%, 250mg

4-Heptyloxybenzaldehyde>98.0%(GC)(T)25mL

3-Chloro-2-fluorobenzeneboronic acid, 97.0%, 5g

Ethyl 3-(2-(((4-(N-((hexan-3-yloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate (Dabigatran Impurity), 97%, 50mg

5-Aminophthalide, 95.0%, 100g

2-(2-Ethylphenyl)-2-propanol, 97.0%, 2.5g

2-Bromo-3-fluorobenzoic Acid>96.0%(GC)(T)1g

(R)-tert-Butyl 3-ethynylpyrrolidine-1-carboxylate, 98+%, 250mg

2-(3-Fluorophenyl)-4-methylthiazole-5-carboxylic acid, 25g

(+/-)-Baclofen, >98%, 25g

1-(3-Fluorobenzyl)-1H-pyrazole-4-carboxylic acid, 1g

Microliter syringe MICROLITER® series 7000 Point type 3, 2.0 µl, 7002 KH, 1 piece